Statement Today, we mark the beginning of National Immunization Awareness Week (NIAW), celebrated each year to highlight and recognize the importance of vaccines to our health. Today, we mark the beginning of National Immunization Awareness Week (NIAW), celebrated each year to highlight and recognize the importance of vaccines to our health. Immunization in Canada and…

April 21, 2022 | Toronto, Ontario | Health Canada As we recover from the COVID-19 pandemic, we must address the existing challenges that were made worse for many Canadians, including those living in long-term care (LTC) homes. Over the last two years, we have seen gaps in infection prevention and control, staffing, and infrastructure, with tragic effects…

Media advisory The Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Kamal Khera, Minister of Seniors, will make an important funding announcement supporting long-term care in Ontario. April 20, 2022, Scarborough, Ontario – The Honourable Jean-Yves Duclos, Minister of Health, and the Honourable Kamal Khera, Minister of Seniors, will make an important funding announcement…

Statement Today, our government announced that it will proceed with Amendments to the Patented Medicines Regulations to provide the Patented Medicine Prices Review Board (PMPRB) with new tools to protect Canadians from excessive prices for patented medicines. April 14, 2022  |  Ottawa, ON  |  Health Canada Today, the Honourable Jean-Yves Duclos, Minister of Health, issued…

April 14, 2022  |  Ottawa, ON  | Health Canada/Public Health Agency of Canada Today, the Honourable Jean-Yves Duclos, Minister of Health, concluded a successful trip to Washington, D.C. As the first Minister of Health to travel to Capitol Hill in over five years, he met with his U.S. counterpart and key stakeholders to discuss shared domestic…

Statement Health Canada authorized Evusheld for the prevention of COVID-19 in immune compromised adults and children. April 14, 2022 | Ottawa, ON | Health Canada Today, Health Canada authorized Evusheld (tixagevimab and cilgavimab) for the prevention of COVID-19. After a thorough and independent scientific review of the evidence, the Department has determined that Evusheld meets…